SDOH Medication Risk Analysis Report (Updated with SDOH Domain Analysis)

1. Key Variables Analysis

Never Visit Outcome
Red = severe risk (never visit), light blue = low risk (visit).

2. Data Preparation (New Variables Created)

New variables: med_risk (Medication Risk Group), sdoh_high (SDOH High Concerns), concern_count (SDOH Concern Count), concern_level (SDOH Concern Level), comprehensive (Comprehensive Risk).

Medication Risk Group
Red = severe medication risk, pink = medium risk, light blue = low risk.

4. SDOH Domain Analysis

SDOH Domain Analysis
SDOH Domain Visualizations:
• Top left: Patient counts by SDOH domain (colored by never visit risk)
• Top right: Never visit rates for top 5 SDOH domains
• Bottom left: Overall SDOH data availability
• Bottom right: Risk level distribution of SDOH domains
Color scheme: Red = high risk (>50% never visit), Pink = medium risk (30-50%), Blue = low risk (<30%)
Patients with specific SDOH concerns: 148
Patients with no SDOH concerns: 0
Missing SDOH domain information: 1,762

Most Common SDOH Domains:
  Physical Activity: 69 patients
  Stress: 59 patients
  Food Insecurity: 14 patients
  Transportation Needs: 14 patients
  Social Connections: 11 patients
  Financial Resource Strain: 9 patients
  Alcohol Use: 5 patients
  Intimate Partner Violence: 3 patients

Never Visit Rates by Top SDOH Domains:
  Physical Activity: 47.8% (n=69)
  Stress: 35.6% (n=59)
  Food Insecurity: 35.7% (n=14)
  Transportation Needs: 57.1% (n=14)
  Social Connections: 9.1% (n=11)

5. Visit Outcome vs Risk Factors


======================================================================
ANALYSIS: Never Visit vs Medication Risk Group
======================================================================

Contingency Table (never_visit vs MED_RISK_GROUP):
MED_RISK_GROUP  High  Medium   All
never_visit                       
0                962     133  1095
1                772      43   815
All             1734     176  1910

Chi-square statistic: 25.5462
P-value: 0.000000
Degrees of freedom: 1
Statistical significance (α=0.05): Yes

Never Visit Rates by MED_RISK_GROUP:
  High: 772/1734 (44.5%)
  Medium: 43/176 (24.4%)

======================================================================
ANALYSIS: Never Visit vs SDOH High Concerns
======================================================================

Contingency Table (never_visit vs HAS_HIGH_SDOH_CONCERNS):
HAS_HIGH_SDOH_CONCERNS   0.0  1.0   All
never_visit                            
0                       1010   85  1095
1                        752   63   815
All                     1762  148  1910

Chi-square statistic: 0.0000
P-value: 1.000000
Degrees of freedom: 1
Statistical significance (α=0.05): No

Never Visit Rates by HAS_HIGH_SDOH_CONCERNS:
  0.0: 752.0/1762.0 (42.7%)
  1.0: 63.0/148.0 (42.6%)

======================================================================
ANALYSIS: Never Visit vs Comprehensive Risk
======================================================================

Contingency Table (never_visit vs comprehensive_risk):
comprehensive_risk  High Med + High SDOH  High Med + Low SDOH  Low Med + High SDOH  Low Med + Low SDOH   All  
never_visit                                                                                                    
0                                     72                  890                   13                 120  1095  
1                                     61                  711                    2                  41   815  
All                                  133                 1601                   15                 161  1910  

Chi-square statistic: 27.2930
P-value: 0.000005
Degrees of freedom: 3
Statistical significance (α=0.05): Yes

Never Visit Rates by comprehensive_risk:
  High Med + High SDOH: 61/133 (45.9%)
  High Med + Low SDOH: 711/1601 (44.4%)
  Low Med + High SDOH: 2/15 (13.3%)
  Low Med + Low SDOH: 41/161 (25.5%)

6. Statistical Summary

This section summarizes the statistical tests and key findings from the above analyses, including chi-square statistics, p-values, and significance for each risk factor comparison.


Report Generated: SDOH Medication Risk Analysis
Clinical Decision Support Tool for SDOH and Medication Risk Stratification